<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="correction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2024.13194</article-id>
<article-id pub-id-type="publisher-id">MMR-29-5-13194</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Jin</surname><given-names>Lu</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Quan</surname><given-names>Jing</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Xiang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>He</surname><given-names>Tao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jia</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Yifan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Gui</surname><given-names>Yaoting</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Shangqi</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Mao</surname><given-names>Xiangming</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yun</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Lai</surname><given-names>Yongqing</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>05</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>03</month>
<year>2024</year></pub-date>
<volume>29</volume>
<issue>5</issue>
<elocation-id>70</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Jin et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Mol Med Rep 16: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="16" page="7072" id="RA1" xlink:href="10.3892/mmr.2017.7470" ext-link-type="doi">7072&#x2013;7079</related-article>, 2017; DOI: 10.3892/mmr.2017.7470</p>
<p>Subsequently to the publication of the above paper, an interested reader drew to the authors&#x2019; attention that, concerrning the Transwell cell migration and invasion assay data shown in <xref rid="f6-mmr-29-5-13194" ref-type="fig">Fig. 6A and B</xref> for the 786-O cell line on p. 7206, the pcDNA3.1-EGOT &#x2018;Migration&#x2019; and &#x2018;Invasion&#x2019; (a-1 and b-1) data panels appeared to contain overlapping sections of data, such that they were potentially derived from the same original source, where these panels were intended to show the results from differently performed experiments. The authors have re-examined their original data, and realize that the &#x2018;Invasion&#x2019; (b-1) panel in <xref rid="f6-mmr-29-5-13194" ref-type="fig">Fig. 6B</xref> was inadvertently chosen incorrectly.</p>
<p>The revised version of <xref rid="f6-mmr-29-5-13194" ref-type="fig">Fig. 6</xref>, now featuring the correct data for the &#x2018;Invasion&#x2019; experiment (B1 in the replacement figure) in <xref rid="f6-mmr-29-5-13194" ref-type="fig">Fig. 6B</xref>, is shown on the next page. Note that this error did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of <italic>Molecular Medicine Reports</italic> for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f6-mmr-29-5-13194" position="float">
<label>Figure 6.</label>
<caption><p>Overexpression of EGOT inhibits RCC cell migration and invasion. Representative images are presented of (A) the migration of 786-O cells, (B) the invasion of 786-O cells, (C) the migration of 786-O cells and (D) the invasion of ACHN cells. Quantification of the invasion and migration of (E) 786-O cells and (F) ACHN cells is displayed. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01. EGOT, eosinophil granule ontogeny transcript; RCC, renal cell carcinoma..</p></caption>
<graphic xlink:href="mmr-29-05-13194-g00.tif"/>
</fig>
</floats-group>
</article>
